Diabetes-induced abnormalities in the myocardium.

Area of Science:

• Cardiology
• Endocrinology
• Biochemistry

Background:

• Diabetic cardiomyopathy is a significant cause of mortality in diabetic patients, distinct from atherosclerosis-related heart disease.
• Diabetic animal models reveal characteristic myocardial abnormalities, including impaired response to stress and altered cardiac enzyme systems.

Purpose of the Study:

• To review the understanding of diabetes-induced myocardial problems and their potential causes.
• To describe findings from laboratory studies attempting to normalize cardiac function in diabetic models.

Main Methods:

• Characterization of diabetes-induced myocardial abnormalities in diabetic rat hearts.
• Assessment of cardiac enzyme systems, including myosin ATPase, sarcoplasmic reticular calcium ATPase, and Na+, K+ ATPase.
• Evaluation of various treatment strategies: insulin, thyroid hormone, carnitine, vanadate, methyl palmoxirate, choline, and methionine.

Main Results:

• Diabetic rat hearts exhibit depressed myosin ATPase (linked to hypothyroidism), sarcoplasmic reticular calcium ATPase, calcium uptake, and Na+, K+ ATPase activity.
• High circulating fats in diabetics may compromise membrane integrity, affecting enzyme activities.
• Insulin treatment partially reversed/prevented changes; thyroid hormone and carnitine normalized specific enzyme defects but not overall function.
• Vanadate treatment showed promise by normalizing both cardiac function and hyperglycemia in diabetic rats.

Conclusions:

• Diabetes induces significant myocardial dysfunction through multiple biochemical pathways, including altered enzyme activities and calcium handling.
• While some treatments address specific defects, normalizing overall cardiac function remains challenging, suggesting multifactorial causes.
• Vanadate emerges as a promising therapeutic agent for diabetic cardiomyopathy, impacting both cardiac function and glycemic control.